This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
46,36 €
Share price
0.00%
Change (1 day)
29.48%
Change (1 year)
Categories
EPS for ChemoCentryx (CCXI)
EPS in 2022 (TTM): -1,70 €
According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -1,69 €. In 2021 the company made an earnings per share (EPS) of -1,69 € a decrease over its 2020 EPS that were of -0,72 €.
EPS history for ChemoCentryx from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -1,70 € | 0.98% |
| 2021 | -1,69 € | 133.33% |
| 2020 | -0,72 € | -16.49% |
| 2019 | -0,86 € | 27.63% |
| 2018 | -0,68 € | -305.41% |
| 2017 | 0,33 € | -142.53% |
| 2016 | -0,78 € | -19.44% |
| 2015 | -0,96 € | -0% |
| 2014 | -0,96 € | 13.68% |
| 2013 | -0,85 € | -16.67% |
| 2012 | -1,02 € |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | 16,46 € | -1,076.72% | 🇺🇸 USA |
 | 3,28 € | -294.74% | 🇺🇸 USA |
 | 3,12 € | -285.22% | 🇬🇧 UK |
 | 3,54 € | -310.05% | 🇺🇸 USA |
 | 12,56 € | -845.25% | 🇺🇸 USA |
 | 12,62 € | -848.68% | 🇺🇸 USA |
 | 1,66 € | -198.41% | 🇺🇸 USA |
 | -1,78 € | 5.82% | 🇮🇱 Israel |
 | 1,62 € | -196.39% | 🇺🇸 USA |